Northwest Biotherapeutics soars on heavy volume

Shares of Northwest Biotherapeutics (NWBO +31.4%) move sharply higher on the session.

More than 4M shares have traded thus far, against a 10-day average of just 365K.

From other sites
Comments (1)
  • reddogloose
    , contributor
    Comments (22) | Send Message
    The move in the stock today is based on a FOX TV report that NWBO's vaccine results in a doubling of survival time for glioblastoma patients compared to standard treatment. This means, roughly 12 months, compared to 6 months. A truly significant treatment would be one that potentially results in a cure. Several other companies are working on vaccines that hold the promise of being far more effective or curative by targeting multiple receptors on target cancer and cancer stem cells… some using dendritic cells. I was a seller today of NWBO shares and view the report as disappointing and sensationalistic. It is the kind of news that should have been reported in a peer reviewed journal or presented at a scientific symposium.
    11 Nov 2013, 10:52 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs